Synaptic Mechanisms of Addiction-Related Behaviors in the Nucleus Accumbens

伏核成瘾相关行为的突触机制

基本信息

  • 批准号:
    8637959
  • 负责人:
  • 金额:
    $ 24.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

Early in my career as a scientist, I decided that communication was the key to all biological processes. This ideology has evolved into a keen interest in the study of synaptic transmission. In the lab of Danny G. Winder, Ph.D. I began my training in synaptic physiology publishing many papers on modulation of excitatory synaptic transmission by metabotropic glutamate receptors and their in vivo recruitment by cocaine. During my postdoctoral training, I have continued to study synaptic transmission in reward related circuitry in the lab of Robert C. Malenka, M.D., Ph.D. Dr. Malenka is a renowned synaptic physiologist and has trained many prominent figures in the synaptic physiology and addiction fields, Antonello Bonci (NIDA), Karl Deisseroth (Stanford), Dan Feldman (UC Berkeley), Pablo Castillo (Albert Einstein), John Isaac (NIH, now Lilly), Anatol Kreitzer (UCSF), Michael Crair (Yale), and Mark Thomas (Univ. Minnesota) to name a few. It is my goal to continue this tradition by obtaining an independent lab in academia studying the role of synaptic transmission in rewarding and aversive behaviors. My area of study differs from Dr. Malenka in that in addition to excitatory transmission, I am also interested in studying inhibitory and neuromodulatory transmission onto NAc interneurons as well as primary output neurons. Eventually, I plan to expand disease models and study effects of aversive states, such as acute and chronic pain, on NAc synaptic circuitry. To do this I am utilizing state of the art techniques and sophisticated yet simple approaches to address these issues in the Nucleus Accumbens (NAc). The ultimate goal of this project is to gain a better understanding of synaptic function in the NAc circuitry and to begin to address how these circuits are recruited to elicit addiction related behaviors. The NAc, as part of the mesolimbic dopamine system, integrates a complex mix of excitatory, inhibitory and modulatory inputs to optimize adaptive motivated behaviors. Dynamic alterations in synaptic transmission within this circuitry are strongly implicated in the development and expression of addictive disorders. The specific aims involve using whole-cell recordings from in vitro slices to define basic properties of NAc neurons and how these are modified by in vivo cocaine exposure. In this proposal, the effects of in vivo cocaine exposure on synaptic properties of NAc output neurons and local microcircuit interneurons (INs) will be delineated utilizing bacterial artificial chromosome (BAC) transgenic marker mice that specifically label direct and indirect pathway medium spiny neurons (MSNs), GABAergic and cholinergic INs. Also, the synaptic properties of three distinct excitatory inputs onto NAc, MSNs and INs will be characterized and the consequences of in vivo cocaine experience on these specific inputs will be determined using virally expressed channel rhodopsin (ChR2). The objectives for the mentored phase of this proposal are: (1) to examine the synaptic properties of direct and indirect MSNs following in vivo cocaine experience, and (2) to determine if specific excitatory synaptic inputs onto these MSNs are differentially altered following in vivo cocaine experience utilizing optogenetic approaches. The independent phase will address: (1) afferent specific basal and drug-induced alterations in excitatory synaptic properties of NAc INs, (2) basal and drug-induced changes in synaptic connectivity between INs and MSNs and (3) behavioral effects of light-induced (ChR2) activation of NAc INs in drug related context, all of which utilize state-of-the-art optogenetic approaches. The results of the proposed experiments will provide a fundamental knowledge of the changes in the synaptic circuitry of the NAc in a pathophysiological state and have implications on future targets for treatment of addiction related behaviors. Additionally, the careful detailed approach of this study provides the foundation for the study of other drugs of abuse and addiction models, as well as additional affirmative disorders associated with maladaptive processes in the NAc. It is my expectation that upon completion of the mentored project I will have the technical and intellectual expertise to successfully run my own independent lab at a respected institute of higher learning. I will have developed to tools to effectively communicate these findings at meetings and in publications. Additionally, it is my belief that upon completion of these projects, I will be able to successfully compete for an R01. Ultimately, this will allow me to continue to contribute to the field of addiction research both by producing quality research and mentoring young scientists.
在我作为一名科学家的职业生涯早期,我认为沟通是所有生物过程的关键。这 意识形态已经演变成对突触传递研究的浓厚兴趣。在丹尼·温德 (Danny G. Winder) 的实验室里, 博士我开始了突触生理学的培训,发表了许多关于兴奋性突触调节的论文 代谢型谷氨酸受体的传递及其在体内被可卡因募集。在我的 博士后培训期间,我继续在实验室研究奖励相关电路中的突触传递 罗伯特·C·马伦卡 (Robert C. Malenka),医学博士、哲学博士Malenka 博士是一位著名的突触生理学家,并培训了许多 突触生理学和成瘾领域的杰出人物:Antonello Bonci (NIDA)、Karl Deisseroth (斯坦福大学)、丹·费尔德曼(加州大学伯克利分校)、巴勃罗·卡斯蒂略(阿尔伯特·爱因斯坦)、约翰·艾萨克(NIH,现为礼来公司)、阿纳托尔 Kreitzer(加州大学旧金山分校)、Michael Crair(耶鲁大学)和 Mark Thomas(明尼苏达大学)等。我的目标是 通过在学术界建立一个研究突触传递作用的独立实验室来延续这一传统 在奖励和厌恶行为中。我的研究领域与马伦卡博士的不同之处在于,除了兴奋性 传输,我也有兴趣研究 NAc 上的抑制和神经调节传输 中间神经元以及初级输出神经元。最终,我计划扩大疾病模型和研究效果 NAc 突触回路上的厌恶状态,例如急性和慢性疼痛。为此,我正在利用状态 Nucleus 中解决这些问题的艺术技巧和复杂而简单的方法 伏隔肌 (NAc)。 该项目的最终目标是更好地了解 NAc 电路中的突触功能并 开始解决如何招募这些回路来引发成瘾相关行为。 NAc,作为 中脑边缘多巴胺系统,整合了兴奋性、抑制性和调节性输入的复杂组合, 优化适应性动机行为。该电路内突触传递的动态变化是 与成瘾性疾病的发展和表达密切相关。具体目标涉及使用 体外切片的全细胞记录,用于定义 NAc 神经元的基本特性以及如何修改这些特性 通过体内可卡因暴露。在该提案中,体内可卡因暴露对突触特性的影响 NAc 输出神经元和局部微电路中间神经元 (IN) 将利用细菌人工来描绘 染色体(BAC)转基因标记小鼠,专门标记直接和间接途径中等刺 神经元 (MSN)、GABA 能和胆碱能 IN。此外,三种不同兴奋性的突触特性 NAc、MSN 和 IN 的输入将被表征,并且体内可卡因体验的后果 这些特定的输入将使用病毒表达的视紫红质通道 (ChR2) 来确定。 该提案指导阶段的目标是:(1)检查直接和 体内可卡因体验后的间接 MSN,以及 (2) 确定特定的兴奋性突触输入是否 利用光遗传学方法在体内可卡因经历后,这些 MSN 上的信息会发生不同的改变。 独立阶段将解决:(1)传入特异性基础和药物引起的兴奋性改变 NAc IN 的突触特性,(2) IN 和 NAc IN 之间突触连接的基础和药物诱导的变化 MSN 和 (3) 在药物相关环境中光诱导 (ChR2) 激活 NAc IN 的行为效应,所有这些 它利用最先进的光遗传学方法。所提出的实验结果将提供 病理生理状态下 NAc 突触回路变化的基础知识 对成瘾相关行为的未来治疗目标具有影响。另外,细心的 这项研究的详细方法为其他药物滥用和成瘾的研究提供了基础 模型,以及与 NAc 适应不良过程相关的其他肯定性障碍。 我期望在完成指导项目后我将拥有技术和智力 专业知识让我能够在一所受人尊敬的高等教育机构成功运营自己的独立实验室。我会有 开发了在会议和出版物中有效传达这些发现的工具。另外,它是 我相信,完成这些项目后,我将能够成功竞争 R01。最终, 这将使我能够通过高质量的研究继续为成瘾研究领域做出贡献 并指导年轻科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brad Alan Grueter其他文献

Brad Alan Grueter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brad Alan Grueter', 18)}}的其他基金

Photoperiodic Programming of Monoamine Brain Circuits
单胺脑回路的光周期编程
  • 批准号:
    10735447
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小白蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    10487428
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小清蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    10298824
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小白蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    10161984
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小清蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    10675558
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小清蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    9923260
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小白蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    9698739
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
小清蛋白中间神经元调节伏隔核突触和行为
  • 批准号:
    9174760
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:
Synaptic Mechanisms of Addiction-Related Behaviors in the Nucleus Accumbens
伏核成瘾相关行为的突触机制
  • 批准号:
    8585390
  • 财政年份:
    2013
  • 资助金额:
    $ 24.9万
  • 项目类别:
Synaptic Mechanisms of Addiction-Related Behaviors in the Nucleus Accumbens
伏核成瘾相关行为的突触机制
  • 批准号:
    8825475
  • 财政年份:
    2013
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

EPPIC-NET DCC
EPPIC-NET DCC
  • 批准号:
    10361021
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:
Abnormal gene splicing in neuropathic pain - Supplement
神经性疼痛中的异常基因剪接 - 补充
  • 批准号:
    10404737
  • 财政年份:
    2021
  • 资助金额:
    $ 24.9万
  • 项目类别:
Abnormal Gene Splicing in Neuropathic Pain
神经性疼痛中的异常基因剪接
  • 批准号:
    10650848
  • 财政年份:
    2020
  • 资助金额:
    $ 24.9万
  • 项目类别:
Abnormal gene splicing in neuropathic pain
神经性疼痛中的异常基因剪接
  • 批准号:
    10588663
  • 财政年份:
    2020
  • 资助金额:
    $ 24.9万
  • 项目类别:
EPPIC-NET DCC
EPPIC-NET DCC
  • 批准号:
    10474719
  • 财政年份:
    2019
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了